N-Boc-4,4-difluoro-L-proline
- CAS No.203866-15-3
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity N-Boc-4,4-difluoro-L-proline is a specialized fluorinated building block designed for advanced pharmaceutical intermediate synthesis. Ideal for oncology research and kinase inhibitor development.
Request a Quote & Full COAProduct Technical Details
Product Overview
N-Boc-4,4-difluoro-L-proline represents a sophisticated class of fluorinated amino acid derivatives essential for modern medicinal chemistry. As a protected proline analog, this compound features a tert-butoxycarbonyl (Boc) group on the nitrogen atom and two fluorine atoms at the 4-position of the pyrrolidine ring. This specific structural modification is strategically designed to enhance the metabolic stability and bioavailability of peptide-based therapeutics.
In the realm of pharmaceutical research, the introduction of fluorine into organic molecules is a critical strategy for optimizing drug candidates. Our high-grade N-Boc-4,4-difluoro-L-proline serves as a vital building block for constructing complex peptide chains and small molecule APIs. The electron-withdrawing nature of the difluoro substitution influences the conformational properties of the proline ring, which can significantly improve binding affinity to biological targets.
Key Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | N-Boc-4,4-difluoro-L-proline |
| CAS Number | 203866-15-3 |
| Molecular Formula | C10H15F2NO4 |
| Molecular Weight | 251.23 g/mol |
| Appearance | White solid |
| Purity (Assay) | ≥97.0% |
| Melting Point | 126-128°C |
| Moisture Content | ≤0.5% |
Industrial Applications
This fluorinated intermediate is predominantly utilized in the synthesis of novel pharmaceutical compounds. It plays a crucial role in the development of structure-activity relationship (SAR) studies, particularly for projects targeting kinase inhibitors. Research indicates that derivatives synthesized using this building block are investigated for their potential as pan-Aurora kinase inhibitors, which are significant in the field of oncology therapeutic development.
Beyond oncology, fluorinated proline derivatives are increasingly valuable in the creation of peptidomimetics with improved pharmacokinetic profiles. The stability provided by the fluorine atoms helps resist enzymatic degradation, thereby extending the half-life of the final drug product. Our material supports both early-stage discovery research and later-stage process development for scale-up.
Quality Assurance and Packaging
We adhere to strict quality control protocols to ensure consistency across every batch. Each production lot undergoes rigorous testing using advanced analytical methods such as HPLC and NMR to verify chemical identity and purity levels. A Certificate of Analysis (COA) is provided with every shipment to guarantee compliance with specified parameters.
- Available in standard 25 kg drums for industrial use.
- Custom packaging solutions available upon request.
- Stored in cool, ventilated conditions to maintain stability.
- Global shipping capabilities with secure handling.
Our commitment to quality extends to our manufacturing process, which is optimized for industrial purity and reproducibility. As a global manufacturer, we understand the critical need for reliable supply chains in the pharmaceutical sector. Contact our technical sales team for detailed information on bulk pricing, lead times, and custom synthesis options tailored to your specific research requirements.
